BR112014018035A8 - Prevenção de doenças inflamatórias em mamíferos domésticos exceto humanos - Google Patents

Prevenção de doenças inflamatórias em mamíferos domésticos exceto humanos

Info

Publication number
BR112014018035A8
BR112014018035A8 BR112014018035A BR112014018035A BR112014018035A8 BR 112014018035 A8 BR112014018035 A8 BR 112014018035A8 BR 112014018035 A BR112014018035 A BR 112014018035A BR 112014018035 A BR112014018035 A BR 112014018035A BR 112014018035 A8 BR112014018035 A8 BR 112014018035A8
Authority
BR
Brazil
Prior art keywords
prevention
humans
inflammatory diseases
domestic mammals
inflammatory
Prior art date
Application number
BR112014018035A
Other languages
English (en)
Other versions
BR112014018035A2 (pt
Inventor
Adlerberth Ingegerd
Rudin Anna
Wold Agnes
Original Assignee
Premune Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Premune Ab filed Critical Premune Ab
Publication of BR112014018035A2 publication Critical patent/BR112014018035A2/pt
Publication of BR112014018035A8 publication Critical patent/BR112014018035A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PREVENÇÃO DE DOENÇAS INFLAMATÓRIAS EM MAMÍFEROS DOMÉSTICOS EXCETO HUMANOS. A presente invenção se refere à utilização de um superantígeno bacteriano para a administração sobre a membrana da mucosa de um mamífero, exceto humano, para a prevenção de desordens inflamatórias, tais como alergias, doenças autoimunes e inflamatórias.
BR112014018035A 2012-02-08 2013-02-05 Prevenção de doenças inflamatórias em mamíferos domésticos exceto humanos BR112014018035A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1250090 2012-02-08
PCT/SE2013/050094 WO2013119170A2 (en) 2012-02-08 2013-02-05 Prevention of inflammatory disorders in domestic non-human mammals

Publications (2)

Publication Number Publication Date
BR112014018035A2 BR112014018035A2 (pt) 2017-06-20
BR112014018035A8 true BR112014018035A8 (pt) 2017-07-11

Family

ID=48948139

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014018035A BR112014018035A8 (pt) 2012-02-08 2013-02-05 Prevenção de doenças inflamatórias em mamíferos domésticos exceto humanos

Country Status (7)

Country Link
US (1) US9375468B2 (pt)
EP (1) EP2726089A4 (pt)
JP (1) JP2015506975A (pt)
AU (1) AU2013217771A1 (pt)
BR (1) BR112014018035A8 (pt)
CA (1) CA2863532A1 (pt)
WO (1) WO2013119170A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016058939A1 (en) 2014-10-14 2016-04-21 Premune Ab Use of superantigens for improving mucosal allergen specific immunotherapy in non-human mammals
WO2016058937A1 (en) 2014-10-14 2016-04-21 Swecure Ab Use of superantigens for improving mucosal allergen specific immunotherapy in human beings

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012818A1 (en) 1990-02-23 1991-09-05 Immulogic Pharmaceutical Corporation Superantigen induced immune non-responsiveness
US5935568A (en) * 1995-05-18 1999-08-10 National Jewish Medical & Research Center Gene therapy for effector cell regulation
JPH09110704A (ja) 1995-10-19 1997-04-28 Chemo Sero Therapeut Res Inst 免疫異常性疾患予防治療用経口投与剤
DE19963840A1 (de) 1999-12-30 2001-09-13 Erika Von Mutius Zusammensetzung zum Vorbeugen und Behandeln von allergischen Erkrankungen
WO2003031471A1 (en) 2001-10-09 2003-04-17 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb)
CN1509725A (zh) 2002-12-24 2004-07-07 沈阳协合集团有限公司 用于提高机体免疫功能的口服金黄色葡萄球菌滤液制剂
SE0401876D0 (sv) * 2004-07-16 2004-07-16 Forskarpatent I Syd Ab Prevention of allergy in children
US8748126B2 (en) * 2005-11-29 2014-06-10 Actogenix N.V. Induction of mucosal tolerance to antigens
KR101527483B1 (ko) * 2007-03-05 2015-06-09 옴 파르마 에스아 호흡기 질환 치료용 박테리아 추출물 및 그 제조방법
WO2011040052A1 (ja) * 2009-10-01 2011-04-07 学校法人日本大学 アトピー性皮膚炎の治療薬

Also Published As

Publication number Publication date
AU2013217771A1 (en) 2014-08-28
EP2726089A2 (en) 2014-05-07
BR112014018035A2 (pt) 2017-06-20
JP2015506975A (ja) 2015-03-05
CA2863532A1 (en) 2013-08-15
US20150079131A1 (en) 2015-03-19
US9375468B2 (en) 2016-06-28
WO2013119170A2 (en) 2013-08-15
EP2726089A4 (en) 2014-05-07
WO2013119170A3 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
BR112014010568A2 (pt) dispositivo dilatador nasal
BR112016017690A2 (pt) Tratamentos para acne resistente
CO6900122A2 (es) Fallo del cliente en clúster
BR112015022095A2 (pt) formulações eutéticas de cloridrato de ciclobenzaprina e cloridrato de amitriptilina
HK1208801A1 (en) Orally administered medical composition
DK2912074T4 (da) Dermal injicerbar steril sammensætning
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
AU2011274619A8 (en) miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
BR112013024423A2 (pt) detecção de doença em plantas
CR20140594A (es) Composiciones farmacéuticas y tratamiento de mastitis
BR112015000329A2 (pt) formulações de diclofenac
BR112017005231A2 (pt) formulações eutéticas de cloridrato de ciclobenzaprina
BR112013017178A2 (pt) arabinogalactanas sulfatadas, apiogalacturonanas e heteroglicanas sulfatadas para o tratamento de doenças causadas pelo vírus influenza
BR112012028773A2 (pt) composições farmacêuticas compreendendo hidromorfona e naloxona
BR112015013615A2 (pt) plantas de melão com resistência ao vírus associado ao amarelecimento do melão (myav)
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
UY34421A (es) Sistema de administración vaginal osmóticamente activo
BR112014013985A2 (pt) formulações orais para tratamento de sobrecarga de metal
DK2437512T3 (da) Social fjernsynstjeneste
BR112014018035A8 (pt) Prevenção de doenças inflamatórias em mamíferos domésticos exceto humanos
MX363385B (es) Métodos para el tratamiento de enfermedad de células falciformes y otras condiciones inflamatorias.
BR112014018851A2 (pt) melhoramento da estabilidade postural administrando droxidopa
BR112014014278A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2447 DE 28-11-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.